Dicerna Pharmaceuticals Analysis
Dicerna Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Dicerna Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what Dicerna Pharmaceuticals is worth, separate from its market price. There are two main types of Dicerna Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Dicerna Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Dicerna Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Dicerna |
Dicerna Stock Analysis Notes
About 89.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.63. Dicerna Pharmaceuticals had not issued any dividends in recent years. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference -based pharmaceuticals. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk AS. Dicerna Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 302 people. To learn more about Dicerna Pharmaceuticals call the company at 617 621-8097 or check out www.dicerna.com.Dicerna Pharmaceuticals Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Dicerna Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Dicerna Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Dicerna Pharmaceuticals is not yet fully synchronised with the market data | |
| Dicerna Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Dicerna Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 192.85 M. Net Loss for the year was (124.44 M) with loss before overhead, payroll, taxes, and interest of (41.08 M). | |
| Over 89.0% of the company shares are held by institutions such as insurance companies |
Dicerna Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.98 B.Dicerna Profitablity
The company has Profit Margin (PM) of (64.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (62.88) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $62.88.Dicerna Pharmaceuticals Outstanding Bonds
Dicerna Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Dicerna Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Dicerna bonds can be classified according to their maturity, which is the date when Dicerna Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Dicerna Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |